171 related articles for article (PubMed ID: 19276209)
1. Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
Boriani G; Biffi M; Martignani C; Diemberger I; Valzania C; Bertini M; Branzi A
QJM; 2009 May; 102(5):349-56. PubMed ID: 19276209
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of implantable cardioverter-defibrillator in today's world.
Boriani G; Cimaglia P; Biffi M; Martignani C; Ziacchi M; Valzania C; Diemberger I
Indian Heart J; 2014; 66 Suppl 1(Suppl 1):S101-4. PubMed ID: 24568820
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator.
Hlatky MA; Sanders GD; Owens DK
Health Aff (Millwood); 2005; 24(1):42-51. PubMed ID: 15647214
[TBL] [Abstract][Full Text] [Related]
4. Should the implantable cardiac defibrillator be used for primary prevention of sudden death? A review of the issues relevant to hospital decision making.
McGregor M; Chen J
Can J Cardiol; 2004 Oct; 20(12):1199-204. PubMed ID: 15494771
[TBL] [Abstract][Full Text] [Related]
5. The cost of implantable defibrillators: perceptions and reality.
Camm J; Klein H; Nisam S
Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
[TBL] [Abstract][Full Text] [Related]
6. Expensive medical technologies and "indication extrapolation": the case of implantable cardioverter-defibrillators.
Simpson CS; Klein GJ; Hoffmaster B
Am Heart J; 2000 Sep; 140(3):419-22. PubMed ID: 10966539
[No Abstract] [Full Text] [Related]
7. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
Ding L; Hua W; Niu H; Chen K; Zhang S
Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillators: an excellent case study.
Stanton MS
Health Aff (Millwood); 2005; 24(1):52-4. PubMed ID: 15647215
[TBL] [Abstract][Full Text] [Related]
10. Editorial: The economical challenge in the treatment of chronic heart failure: is primary prophylactic implantable cardioverter defibrillator therapy cost-effective in Europe?
Cowie MR
Europace; 2009 Oct; 11(10):1407-8; author reply 1408-10. PubMed ID: 19684038
[No Abstract] [Full Text] [Related]
11. Benefits of the implantable cardioverter-defibrillator.
Epstein AE
J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
[TBL] [Abstract][Full Text] [Related]
12. The implantable cardioverter-defibrillator lead: principles, progress, and promises.
Haqqani HM; Mond HG
Pacing Clin Electrophysiol; 2009 Oct; 32(10):1336-53. PubMed ID: 19796348
[TBL] [Abstract][Full Text] [Related]
13. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
14. Implantable defibrillators and beta-blockers in patients with left ventricular dysfunction: economic, ethical, and legal considerations.
Silver MT
Am Heart J; 2007 Apr; 153(4 Suppl):59-64. PubMed ID: 17394904
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule.
Lim HS; Lip GY; Tse HF
Europace; 2008 May; 10(5):536-9. PubMed ID: 18367548
[TBL] [Abstract][Full Text] [Related]
16. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
[TBL] [Abstract][Full Text] [Related]
17. Implantable cardioverter-defibrillators.
Mack MJ
N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
[No Abstract] [Full Text] [Related]
18. Implantable cardioverter/defibrillator therapy: the meaning of terms.
Smith ER
Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
[No Abstract] [Full Text] [Related]
19. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
20. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease.
Walsh EP
Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S38-40. PubMed ID: 18226034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
